How much will The Singapore Economic Development Board (EBD) boost the fund for jobs?
Singapore’s pharmaceutical industry has moved into higher gear, with the opening of a state-of-the-art vaccine plant. The new plant is GlaxoSmithKline’s (GSK) first primary vaccine manufacturing facility and its biggest investment in Asia. The plant, which involves a total investment of S$600 million, underscores GSK’s strong commitment to Singapore. GSK will initially employ about 200 staff and the company is investing in training and development to equip them with the skills and knowledge to operate the new facility. In addition, as part of an ongoing effort to develop talent and leadership in Singapore, GSK is setting up a $30 million endowment fund here to nurture minds in the fields of green manufacturing and public health policy. The Singapore Economic Development Board (EBD) will boost the fund by a further $20 million. Sources: http://www.syndacast.com/pre
Singapore’s pharmaceutical industry has moved into higher gear, with the opening of a state-of-the-art vaccine plant. The new plant is GlaxoSmithKline’s (GSK) first primary vaccine manufacturing facility and its biggest investment in Asia. The plant, which involves a total investment of S$600 million, underscores GSK’s strong commitment to Singapore. GSK will initially employ about 200 staff and the company is investing in training and development to equip them with the skills and knowledge to operate the new facility. In addition, as part of an ongoing effort to develop talent and leadership in Singapore, GSK is setting up a $30 million endowment fund here to nurture minds in the fields of green manufacturing and public health policy. The Singapore Economic Development Board (EBD) will boost the fund by a further $20 million.
